Vivo Bio Tech Ltd share price logo

Vivo Bio Tech Ltd Share Price (511509)

₹38.450.34%

as on

| Source : BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Vivo Bio Tech Ltd Stock Performance

as on August 22, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹37.12
    ₹39.46
    downward going graph

    3.46%

    Downside

    2.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹31.2
    ₹56.9
    downward going graph

    18.86%

    Downside

    47.98%

    Upside

    downward going graph
Previous Close₹38.32
Open₹38.32
Volume33.41K
Upper Circuit₹45.98
Lower Circuit₹30.66
Day's Low37.12
Day's High39.46
52 Week Low31.2
52 Week High56.9
1 Month Return+ 9.11 %
3 Month Return+ 1.48 %
1 Year Return-0.29 %
3 Year Return+ 21.65 %
5 Year Return-27.42 %

Vivo Bio Tech Ltd Stock Fundamentals & Key Indicators

Check Vivo Bio Tech Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹76.64 Cr

Return on Equity (ROE)

4.74

PE Ratio (TTM)

6.98

Return on capital employed (ROCE)

10.06

Industry PE ratio

43.37

Beta (LTM)

0.53

P/B Ratio

1.17

Dividend Yield

0

PEG Ratio

1.85

Quarterly Earnings Growth YOY

688.24

EPS (TTM)

1.7

Sector

Pharmaceuticals

Book Value

36.5

Technical Analysis

Vivo Bio Tech Ltd Stock's Interest Amongst Investors

-34%

Period Aug 22, 2025 to Jul 23, 2025. Change in 30 Days vs previous period

Search interest for Vivo Bio Tech Ltd Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Vivo Bio Tech Ltd Stock Valuation

Track how Vivo Bio Tech Ltd P/E has moved over time to understand its valuation trends.

Vivo Bio Tech Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-339.44x)

January 2, 2023

Today (6.98x)

August 21, 2025

Industry (43.37x)

August 21, 2025

Highest (48.33x)

October 31, 2022

LowHigh

Today’s Price to Earnings Ratio: 6.98x

Vivo Bio Tech Ltd Financial Results

Get the annual and quarterly financial summary of Vivo Bio Tech Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

10 (0%)12 (19%)12 (1%)12 (1%)13 (2%)
Net Income

(in ₹ Cr)

0 (0%)5 (2976%)1 (84%)1 (29%)1 (26%)
Net Profit Margin1.68% (0%)43.44% (2486%)6.72% (85%)8.62% (28%)10.71% (24%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

81 (0%)122 (51%)123 (0%)137 (11%)
Total Liabilities

(in ₹ Cr)

39 (0%)75 (96%)71 (6%)83 (16%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

8 (0%)14 (83%)16 (17%)15 (10%)16 (7%)

Vivo Bio Tech Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Vivo Bio Tech Ltd.

  • Vivo Bio Tech Ltd Earnings Results

    Vivo Bio Tech Ltd’s net profit jumped 688.24% since last year same period to ₹1.34Cr in the Q1 2025-2026. On a quarterly growth basis, Vivo Bio Tech Ltd has generated 26.42% jump in its net profits since last 3-months.

    Read More about Earnings Results

Vivo Bio Tech Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Vivo Bio Tech Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
39.06%
-7.62
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
60.94%
5.58
Others
0%
0.00

Vivo Bio Tech Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Vivo Bio Tech Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA76.64-5.48%0.79245
NA219.61409.45%0.56-1215
NA137.71-11.79%0.001269
NA8.288.75%0.76NA27
NA264.040.76%0.009162

Vivo Bio Tech Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Vivo Bio Tech Ltd.

  • Vivo Bio Tech Reports Strong Profit Growth - 20 May, 2025

    Vivo Bio Tech's consolidated net profit surged 43.24% to Rs 1.06 crore in Q1 March 2025, with annual profit rising 187.75% to Rs 7.28 crore. Sales also increased.

Insights on Vivo Bio Tech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Vivo Bio Tech stock has moved up by 4.4%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 57.71% to 60.94% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 12.22 Cr → 12.65 Cr (in ₹), with an average increase of 1.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 0.82 Cr → 1.34 Cr (in ₹), with an average increase of 21.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 171.3% return, outperforming this stock by 171.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 271.2% return, outperforming this stock by 249.6%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 42.29% to 39.06% in Jun 2025 quarter

About Vivo Bio Tech Ltd

Vivo Bio Tech is a full service CRO that provides a range of drug development and discovery services tailored to the needs of global pharmaceutical and biotechnology companies in accordance with OECD AAALAC IND guidelines. With experienced and talented scientists, our services include In vitro and In vivo toxicity studies, pharmacological investigations, pharmacokinetics, toxicokinetic studies, gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Additionally, we offer services for pharmacologic, toxicological and bioanalytical investigations for drug discovery and development, including bacterial reverse mutation assays, chromosomal aberration and micronucleus. Our Invivo Services group provides both nonregulatory and regulatory IND enabling preclinical development services as well as design and development of xenograft models for evaluation of anticancer agents. We have also partnered with Taconic for sourcing foundation and expansion colonies of animal models, in addition to beginning in-house breeding of Specific Pathogen Free rodents.

Revenue: ₹12.51Cr as on June 2025 (Q1 FY26)
Net Profit: ₹1.34Cr as on June 2025 (Q1 FY26)
Chairperson Name: K Sunder
OrganisationVivo Bio Tech Ltd
HeadquartersSecunderabad
IndustryPharmaceuticals
CEOK Sunder
E-voting on sharesClick here to vote

FAQs

What is Vivo Bio Tech Ltd share price today?

Vivo Bio Tech Ltd share price today stands at ₹38.45, Open: ₹38.32, Previous Close: ₹38.32, High: ₹39.46, Low: ₹37.12, 52 Week High: ₹56.9, 52 Week Low: ₹31.2 as on .

How to buy Vivo Bio Tech Ltd shares ?

To buy Vivo Bio Tech Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 511509 or Vivo Bio Tech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Vivo Bio Tech Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Vivo Bio Tech Ltd?

Today's traded volume of Vivo Bio Tech Ltd is 33.41K. Which means that 33.41K shares of Vivo Bio Tech Ltd were bought and sold on the stock market during today's trading session.

What is Vivo Bio Tech Ltd's market cap today?

Today's market capitalisation of Vivo Bio Tech Ltd is ₹76.64 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd’s 52 week high is ₹56.9 and 52 week low is ₹31.2. The current share price of Vivo Bio Tech Ltd is ₹38.45, which is -32.43% down from its 52 week high and 23.24% up from its 52 week low.